[PDF][PDF] Profiling Antichlamydial Compounds in Monocyte and Macrophage Cell Models

M Kortesoja - 2020 - helda.helsinki.fi
Chlamydia pneumoniae is an obligate intracellular human pathogen whose primary site of
infection is the respiratory tract. In addition to respiratory tract infections, such as sinusitis …

Assaying Chlamydia pneumoniae Persistence in Monocyte-Derived Macrophages Identifies Dibenzocyclooctadiene Lignans as Phenotypic Switchers

E Taavitsainen, M Kortesoja, T Bruun, NG Johansson… - Molecules, 2020 - mdpi.com
Antibiotic-tolerant persister bacteria involve frequent treatment failures, relapsing infections
and the need for extended antibiotic treatment. The virulence of an intracellular human …

Chlamydia Pneumoniae and Chronic Diseases with a Great Impact on Public Health

R Sessa, P Cipriani, M Di Pietro… - International …, 2008 - journals.sagepub.com
Chlamydia pneumoniae is recognised as a common cause of respiratory tract infections and
has recently been implicated in several extrapulmonary chronic diseases, with great impact …

[HTML][HTML] A platform for studying the transfer of Chlamydia pneumoniae infection between respiratory epithelium and phagocytes

M Kortesoja, RE Trofin, L Hanski - Journal of microbiological methods, 2020 - Elsevier
The obligate intracellular bacterium, Chlamydia pneumoniae, has been identified as a risk
factor for several chronic inflammatory diseases in addition to respiratory tract infections. The …

Degradation of Chlamydia pneumoniae by Peripheral Blood Monocytic Cells

K Wolf, E Fischer, T Hackstadt - Infection and immunity, 2005 - Am Soc Microbiol
Chlamydia pneumoniae is a common human respiratory pathogen that has been associated
with a variety of chronic diseases, including atherosclerosis. The role of this organism in the …

Relevance of Chlamydia pneumoniae murine pneumonitis model to evaluation of antimicrobial agents

ND Masson, CD Toseland… - Antimicrobial agents and …, 1995 - Am Soc Microbiol
A mouse model of Chlamydia pneumoniae pneumonitis was established in outbred MF1
mice immunosuppressed with cyclophosphamide. Following intranasal inoculation with 2.2 …

Dibenzocyclooctadiene lignans from Schisandra spp. selectively inhibit the growth of the intracellular bacteria Chlamydia pneumoniae and Chlamydia trachomatis

E Hakala, L Hanski, H Uvell, T Yrjönen… - The Journal of …, 2015 - nature.com
Lignans from Schisandra chinensis berries show various pharmacological activities, of
which their antioxidative and cytoprotective properties are among the most studied ones …

Chlamydia pneumoniae and atherosclerosis

RJ Belland, SP Ouellette, J Gieffers… - Cellular …, 2004 - Wiley Online Library
Exposure to Chlamydia pneumoniae is extremely common, and respiratory infections occur
repeatedly among most people. Strong associations exist between C. pneumoniae infection …

Chlamydia pneumoniae Infection and Inflammatory Diseases

RA Porritt, TR Crother - Onco Therapeutics, 2016 - dl.begellhouse.com
Chlamydia pneumonia, an obligate intracellular bacterial pathogen, has long been
investigated as a potential developmental or exacerbating factor in various pathologies. Its …

Vascular Responses to Chlamydia pneumoniae Infection

ME Rosenfeld, LA Campbell - Vascular Responses to Pathogens, 2016 - Elsevier
Chlamydia pneumoniae is an obligate intracellular pathogen that has been found in
atherosclerotic lesions and chronic infection has been linked to an increased risk of …